213 related articles for article (PubMed ID: 18474618)
1. MicroRNA-126 regulates HOXA9 by binding to the homeobox.
Shen WF; Hu YL; Uttarwar L; Passegue E; Largman C
Mol Cell Biol; 2008 Jul; 28(14):4609-19. PubMed ID: 18474618
[TBL] [Abstract][Full Text] [Related]
2. HOXA9 regulates miR-155 in hematopoietic cells.
Hu YL; Fong S; Largman C; Shen WF
Nucleic Acids Res; 2010 Sep; 38(16):5472-8. PubMed ID: 20444872
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C-mediated phosphorylation of the leukemia-associated HOXA9 protein impairs its DNA binding ability and induces myeloid differentiation.
Vijapurkar U; Fischbach N; Shen W; Brandts C; Stokoe D; Lawrence HJ; Largman C
Mol Cell Biol; 2004 May; 24(9):3827-37. PubMed ID: 15082777
[TBL] [Abstract][Full Text] [Related]
4. miR-647 inhibits glioma cell proliferation, colony formation and invasion by regulating HOXA9.
Qin K; Tian G; Chen G; Zhou D; Tang K
J Gene Med; 2020 Mar; 22(3):e3153. PubMed ID: 31881106
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells.
Schneider E; Pochert N; Ruess C; MacPhee L; Escano L; Miller C; Krowiorz K; Delsing Malmberg E; Heravi-Moussavi A; Lorzadeh A; Ashouri A; Grasedieck S; Sperb N; Kumar Kopparapu P; Iben S; Staffas A; Xiang P; Rösler R; Kanduri M; Larsson E; Fogelstrand L; Döhner H; Döhner K; Wiese S; Hirst M; Keith Humphries R; Palmqvist L; Kuchenbauer F; Rouhi A
Leukemia; 2020 May; 34(5):1253-1265. PubMed ID: 31768018
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-652-3p promotes the proliferation and invasion of the trophoblast HTR-8/SVneo cell line by targeting homeobox A9 to modulate the expression of ephrin receptor B4.
Shi Z; Liu B; Li Y; Liu F; Yuan X; Wang Y
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):587-596. PubMed ID: 30839116
[TBL] [Abstract][Full Text] [Related]
7. Homeobox A9 directly targeted by miR-196b regulates aggressiveness through nuclear Factor-kappa B activity in non-small cell lung cancer cells.
Yu SL; Lee DC; Sohn HA; Lee SY; Jeon HS; Lee JH; Park CG; Lee HY; Yeom YI; Son JW; Yoon YS; Kang J
Mol Carcinog; 2016 Dec; 55(12):1915-1926. PubMed ID: 26586336
[TBL] [Abstract][Full Text] [Related]
8. Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.
Zeisig BB; Milne T; García-Cuéllar MP; Schreiner S; Martin ME; Fuchs U; Borkhardt A; Chanda SK; Walker J; Soden R; Hess JL; Slany RK
Mol Cell Biol; 2004 Jan; 24(2):617-28. PubMed ID: 14701735
[TBL] [Abstract][Full Text] [Related]
9. MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.
Wang K; Jin J; Ma T; Zhai H
J Cell Mol Med; 2017 Dec; 21(12):3730-3740. PubMed ID: 28780773
[TBL] [Abstract][Full Text] [Related]
10. Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes.
Wang GG; Pasillas MP; Kamps MP
Mol Cell Biol; 2006 May; 26(10):3902-16. PubMed ID: 16648484
[TBL] [Abstract][Full Text] [Related]
11. [HOXA9 is direct target of miR-196a].
Dou LP; Li YH; Wang LL; Yu L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Feb; 27(2):166-9. PubMed ID: 21315047
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-365 induces apoptosis and inhibits invasion of human myeloma cells by targeting homeobox A9 (HOXA9).
Gao Y; Miao Y; Zhang W; Ru X; Hou L
Environ Toxicol Pharmacol; 2021 Jul; 85():103627. PubMed ID: 33621688
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-320a Regulates the Osteogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells by Targeting HOXA10.
Huang J; Meng Y; Liu Y; Chen Y; Yang H; Chen D; Shi J; Guo Y
Cell Physiol Biochem; 2016; 38(1):40-8. PubMed ID: 26741129
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development.
Schneider E; Staffas A; Röhner L; Krowiorz K; Heuser M; Döhner K; Bullinger L; Döhner H; Fogelstrand L; Rouhi A; Kuchenbauer F; Palmqvist L
Exp Hematol; 2016 Dec; 44(12):1166-1171. PubMed ID: 27619068
[TBL] [Abstract][Full Text] [Related]
16. Molecular regulators of HOXA9 in acute myeloid leukemia.
Aryal S; Zhang Y; Wren S; Li C; Lu R
FEBS J; 2023 Jan; 290(2):321-339. PubMed ID: 34743404
[TBL] [Abstract][Full Text] [Related]
17. MiR-638 serves as a tumor suppressor by targeting HOXA9 in glioma.
Zheng DH; Wang X; Lu LN; Chen DL; Chen JM; Lin FM; Xu XB
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7798-7806. PubMed ID: 30536324
[TBL] [Abstract][Full Text] [Related]
18. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.
Popovic R; Riesbeck LE; Velu CS; Chaubey A; Zhang J; Achille NJ; Erfurth FE; Eaton K; Lu J; Grimes HL; Chen J; Rowley JD; Zeleznik-Le NJ
Blood; 2009 Apr; 113(14):3314-22. PubMed ID: 19188669
[TBL] [Abstract][Full Text] [Related]
19. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-1294 targets HOXA9 and has a tumor suppressive role in osteosarcoma.
Zhang ZF; Li GR; Cao CN; Xu Q; Wang GD; Jiang XF
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8582-8588. PubMed ID: 30575897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
